FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway
Open accessThe DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
FLN29 was identified as an interferon (IFN)-inducible gene, and it has been shown to suppress Toll-like receptor 4-mediated NF-kappaB activation by binding to TRAF6. To elucidate the physiological roles of FLN29, we generated FLN29-deficient mice. FLN29 deficiency resulted in hyper-response to LPS both in vivo and in vitro, demonstrating the negative regulatory role of FLN29 in TLR4 signaling. Furthermore, we found that FLN29(-/-) mice exhibited increased susceptibility to poly(I:C)-induced septic shock compared with WT mice. FLN29(-/-) fibroblasts were highly resistant to vesicular stomatitis virus infection, and these cells produced more IFN-beta than WT cells did in response to not only intracellular poly(I:C) but also overexpression of IPS-1. Forced expression of FLN29 inhibited the IPS-1-dependent activation of both NF-kappaB and IRF3. We also found that FLN29 could interact with TRIF, IPS-1, TRAF3, and TRAF6. Together, these results suggest that FLN29, in addition to playing a negative regulatory role in the TLR4 signaling pathway, negatively regulates the RIG-I-like helicase signaling pathway at the level of IPS-1/TRAF6 and IPS-1/TRAF3 complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, transient up-regulation of the mRNA encoding the negative immune regulator Trafd1 (34) (Fig. 3F) is the main cause of a strong increase in its protein.”
From Dynamic profiling of the protein life cycle in response to pathogens (2015) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Self-citationSato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,339
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S., & Colonna, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603082103 · Cited by 1,169
Cited by
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
Dynamic profiling of the protein life cycle in response to pathogens
Jovanovic, M., Rooney, M. S., Mertins, P., Przybylski, D., Chevrier, N., Satija, R., Rodriguez, E. H., Fields, A. P., Schwartz, S., Raychowdhury, R., et al. (2015) · Science · doi:10.1126/science.1259038 · Cited by 460
“3F) (34) is the main cause of a strong increase in its protein.”
BackgroundPaz, S., Vilasco, M., Werden, S. J., Arguello, M., Joseph-Pillai, D., Zhao, T., Nguyên, T. L.-A., Sun, Q., MEURS, E. F., Lin, R., et al. (2011) · Cell Research · doi:10.1038/cr.2011.2 · Cited by 168
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population
Bray, S. M., Mulle, J. G., Dodd, A. F., Pulver, A. E., Wooding, S., & Warren, S. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004381107 · Cited by 118
Regulation of RLR-mediated innate immune signaling – It is all about keeping the balance
Eisenächer, K., & Krug, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.01.011 · Cited by 136
“…et al. (2008) EYA4 IPS-1, NLRX1 Association with IPS-1 and NLRX1 Okabe et al. (2009) FLN29 IPS-1, TRAF3, TRAF6 Interaction with IPS-1, TRAF3 and TRAF6 Sanada et al. (2008) PLK1 IPS-1 Disruption of IPS-1-TRAF3 interaction Vitour et al. (2009) Targeting the stability of IPS-1 PSMA7 IPS-1…”
BackgroundHe, H., Zheng, N., Song, Z., Kim, K. H., Yao, C., Zhang, R., Zhang, C., Huang, Y., Uckun, F. M., Cheng, J., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b05470 · Cited by 121
Balan, I. S., Beattie, M. C., O’Buckley, T. K., Aurelian, L., & Morrow, A. L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37409-6 · Cited by 129
Hildebrand, J. M., Yi, Z., Buchta, C. M., Poovassery, J., Stunz, L. L., & Bishop, G. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01055.x · Cited by 110
Sasai, M., Tatematsu, M., Oshiumi, H., Funami, K., Matsumoto, M., Hatakeyama, S., & Seya, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2009.12.002 · Cited by 102
Immune correlates of tuberculosis disease and risk translate across species
Ahmed, M., Thirunavukkarasu, S., Rosa, B. A., Thomas, K. A., Das, S., Rangel-Moreno, J., Lu, L., Mehra, S., Mbandi, S. K., Thackray, L. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0233 · Cited by 89
“9 of 17 Finger Domain Containing 1) belongs to the tumor necrosis factor (TNF) family–like genes and is a negative feedback regulator of the Toll-like receptor (TLR) signaling pathway, which results in the control of excessive immune responses (43, 44).”
BackgroundMethodInfluentialCytoplasmic nucleic acid sensors in antiviral immunity
Ranjan, P., Bowzard, J. B., Schwerzmann, J., Jeisy-Scott, V., Fujita, T., & Sambhara, S. R. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.003 · Cited by 99
Lectin Site Ligation of CR3 Induces Conformational Changes and Signaling
O'Brien, X. M., Heflin, K. E., Lavigne, L. M., Yu, K., Kim, M., Salomon, A. R., & Reichner, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298307 · Cited by 66
“Also representedwere peptides known to be involved in the cellular response to other PAMPs, including ERK2 and TRAF (TNF receptor-associated factor)type zinc finger domain-containing protein 1, the former of which was confirmed byWestern blot analysis (26, 30) (supplemental Fig.”
BackgroundSiegfried, A., Berchtold, S., Manncke, B., Deuschle, E., Reber, J., Ott, T., Weber, M., Kalinke, U., Hofer, M. J., Hatesuer, B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203305 · Cited by 70
“Based on previous studies that suggested a negative regulatory role of IFIT2 in the proinflammatory response (22, 37, 38), we sought to analyze the influence of IFIT2 on proinflammatory responses in vivo.”
BackgroundYoshida, H., Kimura, A., Fukaya, T., Sekiya, T., Morita, R., Shichita, T., Inoue, H., & Yoshimura, A. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2011.12.156 · Cited by 63
“Phosphorylation was analyzed by SDS–PAGE and Western blotting as described previously [15], with the following Abs: antiphospho-STAT1 (Tyr(701); Cell Signaling Technology), anti-phospho-STAT3 (Tyr(705); Cell Signaling Technology), anti-phosphoSTAT6 (Tyr(641); Cell Signaling Technology), anti-phospho-Smad2 (Ser; Cell S…”
MethodSelf-citationRetinoic acid inducible gene-I, more than a virus sensor
Liu, F., & Gu, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1045-y · Cited by 58
“A20, SIKE and FLN29 suppress RIG-I signaling through the interaction with other downstream molecules (Huang et al., 2005; Saitoh et al., 2005; Sanada et al., 2008).”
BackgroundKim, T. H., & Zhou, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133450 · Cited by 62
Richards, K. H., & Macdonald, A. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2010.12.007 · Cited by 55
miR-34a as hub of T cell regulation networks
Hart, M., Walch‐Rückheim, B., Krammes, L., Kehl, T., Rheinheimer, S., Tänzer, T., Glombitza, B., Sester, M., Lenhof, H., Keller, A., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0670-5 · Cited by 51
van der Graaf, A., Zorro, M. M., Claringbould, A., Võsa, U., Aguirre‐Gamboa, R., Li, C., Mooiweer, J., Ricaño-Ponce, I., Borek, Z., Koning, F., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.562434 · Cited by 67
Nakagawa‐Senda, H., Hachiya, T., Shimizu, A., Hosono, S., Oze, I., Watanabe, M., Matsuo, K., Ito, H. M., Hara, M., Nishida, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19914-w · Cited by 44
Chang, M. X. (2021) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2021.104038 · Cited by 38
Radwan, M., Wilkinson, D., Hui, W., Destrument, A., Charlton, S. H., Barter, M. J., Gibson, B. G., Coulombe, J., Gray, D. A., Rowan, A. D., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204962 · Cited by 34
Martínez, I., Oliveros, J. C., Cuesta, I., de la Barrera, J., Ausina, V., Casals, C., de Lorenzo, A., García, E., García-Fojeda, B., Garmendia, J., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00276 · Cited by 32
“, 2002), (ii) TRAFD1 (Figure 1), which is a negative regulator of Toll-like receptor (TLR) and RIG-I-like signaling pathways (Mashima et al., 2005; Sanada et al., 2008), and (iii) the deubiquitinase TNFα induced protein 3 (TNFAIP3/A20, Figure 1), which is a master regulator of inflammation and the innate immune respon…”
BackgroundBubier, J. A., Philip, V. M., Quince, C., Campbell, J. H., Zhou, Y., Vishnivetskaya, T. A., Duvvuru, S., Blair, R. H., Ndukum, J., Donohue, K. D., et al. (2020) · Genetics · doi:10.1534/genetics.119.303013 · Cited by 41
TRAF3: a novel tumor suppressor gene in macrophages
Lalani, A., Luo, C., Han, Y., & Xie, P. (2015) · Macrophage · doi:10.14800/macrophage.1009 · Cited by 33
“Examples of such adaptor proteins include TANK [50, 51] , TRADD [52] , UXT-V1 [53] , DOK3 [54] , A20 [55] , TAX1BP1 [55] , UBXN1 [56] , optineurin [57] , TRAM [58] , and FLN29 [59] .”
An Integrative Framework Reveals Signaling-to-Transcription Events in Toll-like Receptor Signaling
Mertins, P., Przybylski, D., Yosef, N., Qiao, J., Clauser, K. R., Raychowdhury, R., Eisenhaure, T., Maritzen, T., Haucke, V., Satoh, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.016 · Cited by 30
“Furthermore, several phosphoproteins were reported to function in TLR signaling by independent studies: TRAFD1 (Sanada et al., 2008), STK3 (Geng et al., 2015), ULK1 (Eriksen et al., 2015), and CORO1A (Tanigawa et al., 2009).”
BackgroundSun, J., Ding, Q., Chen, Y., Li, J., Wang, Z., Wei, Z., Ge, X., & Zhang, L. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.05.031 · Cited by 25
Guégan, J., Pollet, J., Ginestier, C., Charafe‐Jauffret, E., Peter, M. E., & Legembre, P. (2021) · iScience · doi:10.1016/j.isci.2021.103538 · Cited by 26
“On the other hand, TRAF-D1 and COMMD7 were not detected in HEK/293T and MDA-MB231 cells, indicating that either these factors were present in the unstimulated CD95 complex but to a lesser extent when compared with KPC2 and p65 or that these factors corresponded to false-positive hits.”
InfluentialGupta, S., Singh, P. K., Tasneem, A., Almatroudi, A., Rahmani, A. H., Dohare, R., & Parveen, S. (2022) · Genes · doi:10.3390/genes14010042 · Cited by 26
“TRAFD1 expression is inducible by interferon and suppresses Toll-like receptor 4-mediated NF-κB activation by binding to tumor necrosis receptor associated factor 6 (TRAF6) [48].”
BackgroundGalinato, M. H., Shimoda, K., Aguiar, A., Hennig, F., Boffelli, D., McVoy, M. A., & Hertel, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00577 · Cited by 24
“Compared to the rest of the population, GEMM cells contained higher levels (median ratio, ∼1.5-fold) of transcripts encoding sensors of viral double-stranded DNA and RNA, such as IFI16 (Unterholzner et al., 2010), HMGB1 (Yanai et al., 2009), DDX58/RIG-I (Pichlmair et al., 2006), IFIH1/MDA5 (Kato et al., 2006) and EIF2…”
BackgroundInfluentialHou, X., Zhang, R., Yang, M. G., Niu, N., Zong, W., Yang, L., Li, H., Hou, R., Wang, X., Wang, L., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02669 · Cited by 27
A higher burden of multiple sclerosis genetic risk confers an earlier onset
Misicka, E., Davis, M. F., Kim, W., Brugger, S. W., Beales, J. T., Loomis, S. J., Bronson, P. G., & Briggs, F. B. S. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211053155 · Cited by 23
Fabrik, I., Link, M., Putzová, D., Plzakova, L., Lubovská, Z., Philimonenko, V. V., Pávková, I., Řehulka, P., Kročová, Z., Hozák, P., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000160 · Cited by 19
Ke, Y., Wang, C., Liu, S., Kuang, Y., Tao, Q., & Hu, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68312 · Cited by 20
“Considering the contact between NF-κB and RIG-I-like receptor or Nod-like receptor signaling pathways [18,19], we postulated that DIRAS2 most likely inhibits the NF-κB signaling pathway.”
BackgroundJia, P., Liu, W., Chen, L., Jin, Y., Zhang, J., Jia, K., & Yi, M. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.11.047 · Cited by 17
“FLN29 played a negative regulation role in the RLR signaling pathway at the level of interferon-b promoter stimulator1 (IPS-1)/tumor necrosis factor receptor-associated factor (TRAF) 6 and IPS-1/TRAF3 complexes [6].”
BackgroundNegative regulation of human mononuclear phagocyte function
Hedl, M., & Abraham, C. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.139 · Cited by 19
Black carp TRAFD1 restrains MAVS-mediated antiviral signaling during the innate immune activation
Yan, J., Zhang, Y., Tan, Y., Dai, Y., Wei, J., Cao, Y., & Feng, H. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.04.045 · Cited by 16
Hazlewood, J. E., Dumenil, T. D., Le, T. T., Slonchak, A., Kazakoff, S. H., Patch, A., Gray, L.-A., Howley, P. M., Liu, L., Hayball, J. D., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009215 · Cited by 15
TRAFD1 (FLN29) Interacts with Plekhm1 and Regulates Osteoclast Acidification and Resorption
Witwicka, H., Jia, H., Kutikov, A. B., Reyes‐Gutierrez, P., Li, X., & Odgren, P. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127537 · Cited by 16
Takechi, R., Galay, R. L., Matsuo, T., Maeda, H., Kusakisako, K., Talactac, M. R., Mochizuki, M., Fujisaki, K., & Tanaka, T. (2015) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2015.08.002 · Cited by 12
Ailenberg, M., Ciano‐Oliveira, C. D., Szászi, K., Dan, Q., Rozycki, M., Kapùs, A., & Rotstein, O. D. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13162 · Cited by 11
“Activated Rac is also known to lead to activation of SAPK/ JNK (Sanada et al., 2008).”
BackgroundLi, L., Yang, R., Feng, M., Guo, Y., Wang, Y., Guo, J., & Lü, X. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.035 · Cited by 9
Qian, Y., Liu, Z., Liu, Q., Tian, X., Mo, J., Leng, L., Wang, C., Xu, G., Zhang, S., & Xie, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094431 · Cited by 8
“A total of 1 µ g total RNA was employed for reverse transcription analysis, using the Primer Script Fast RT Reagent Kit with gDNA eraser (RR092S) (Takara, Tokyo, Japan).”
InfluentialBando, S. Y., Iamashita, P., Silva, F. N., Costa, L. D. F., Abe, C. M., Bertonha, F. B., Guth, B. E. C., Fujita, A., & Moreira‐Filho, C. A. (2019) · Microorganisms · doi:10.3390/microorganisms7070195 · Cited by 7
“TRAFD1 (alias FLN29) acts as a negative regulator of excessive microbial immune response through Toll-like receptor and retinoic acid-inducible gene I (RIG-I)-like helicase signaling pathway [51].”
BackgroundHeikkilä, A., Sliz, E., Huilaja, L., FinnGen, Reis, K., Priit, P., Elnahas, A. G., Reigo, A., Esko, T., Laisk, T., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.043 · Cited by 8
Zhao, N., Zhang, X., Wang, X., Liu, Z., Zheng, G., Zhang, X., Schiöth, H. B., Sun, C., Wang, H., & Zhang, Y. (2024) · Virulence · doi:10.1080/21505594.2024.2422540 · Cited by 6
“However, mice lacking TRAFD1 show a high level of resistance to infection by vesicular stomatitis virus [35].”
Regulation of virus-triggered type I interferon signaling by cellular and viral proteins
Zhong, B., Wang, Y., & Shu, H. (2010) · Frontiers in Biology · doi:10.1007/s11515-010-0013-x · Cited by 6
“TRAF6 and inhibits virus-triggered signaling at TRAF3/6 level (Sanada et al., 2008).”
BackgroundNakayasu, E. S., Brown, R. N., Ansong, C. K., Sydor, M. A., Imtiaz, S., Mihai, C., Sontag, R. L., Hixson, K. K., Monroe, M. E., Sobreira, T. J. P., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026138 · Cited by 3
Pani, S., Ganguly, B., & Samanta, M. (2025) · Aquaculture International · doi:10.1007/s10499-025-02399-6 · Cited by 2
“RIPK1 mediates stress signalling from death receptors/TLRs (Newton 2015), while TRAFD1 negatively modulates RLR signalling (Sanada et al. 2008).”
A Role for Interferon Stimulated Gene-15 (ISG15) During Chikungunya Virus Infection
Werneke, S. W. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k73r0qw3 · Cited by 2
Hepatocytes Response to Interferon Alpha Levels Recorded After Liver Resection
Kuklin, A., Tokovenko, B. T., Makogon, N., Oczko‐Wojciechowska, M., Jarząb, B., & Obolenskaya, M. Y. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0125 · Cited by 2
Laezza, M., Pisapia, L., Toro, B., Mercadante, V., Rispo, A., Gianfrani, C., & Pozzo, G. D. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100240 · Cited by 1
“Otherwise, a depletion of TRAFD1 in human cells or KO mice determines an increased susceptibility to LPS with amplified production of pro-inflammatory cytokines [12,13].”
Chen, B., Wang, H., Yang, Y., Wang, W., Zuo, M., Zhou, J., Tang, S., Zhai, R., Liu, S., Ai, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115747 · Cited by 1
Wang, B., Cai, X., Li, M., Liu, X., 薛俊慧, Liu, Y., Ai, D., & Hu, X. (2026) · Advanced Science · doi:10.1002/advs.202518950 · Cited by 2
Basova, L., Riley, T., Franklin, D., Delorme, V., Lim, W. L., Grant, I., Letendre, S. L., Iudicello, J. E., Cherner, M., Ellis, R. J., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100873 · Cited by 1
“TRAFD1 plays a role in regulating anti-viral responses (Sanada et al., 2008).”
BackgroundIdentification of Causal Rare Variants in an Extended Pedigree with Obsessive-compulsive Disorder
Rajendram, R. (2014) · TSpace (University of Toronto) · Cited by 1
Guégan, J., Pollet, J., Ginestier, C., Charafe‐Jauffret, E., Peter, M. E., & Legembre, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.07.438830 · Cited by 1
“On the other hand, TRAF-D1 and COMMD7 were not detected in HEK293T and MDA-MB-231 cells indicating that either these factors were present in CD95 complex but to a lesser extent as compared to KPC2 and p65 or that they corresponded to false positive hits.”
BackgroundSuppression of Pulmonary Innate Immunity by Pneumoviruses
Dhar, J. (2016) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Higaki, P. I. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-20022018-131845
Aguilan, J. T., Pedrosa, E., Dolstra, H., Baykara, R. N., Barnes, J., Zhang, J., Sidoli, S., & Lachman, H. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.08.548192 · Cited by 1
Gorman, B. M. [. L. N. L. (2024) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Zhang, M., Brown, M. R., Bentley, A. R., Winkler, T. W., Noordam, R., Nagarajan, P., Guo, B., Lee, S., Schwander, K., Wang, W., et al. (2025) · medRxiv · doi:10.1101/2025.10.06.25337440
“TRAFD1 is a protein-coding gene that is primarily related to immune and inflammatory responses via its interactions with NF-κB and TNF receptor signaling pathways 33, 34 .”
Étude de la régulation de la protéine mitochondriale MAVS au cours de l’immunité innée antivirale
Castanier, C. (2011) · theses.fr (ABES) · doi:10.70675/1ad655f2z8bf1z4a47zba70z55e456a89d8a
Principes moléculaires du mécanisme d'activation du récepteur de l'immunité innée RIG-I
Louber, J. (2013) · theses.fr (ABES) · doi:10.70675/e120bbddz64b9z4dacz906bz5017157940dc
Zhang, Q., Zhang, Y., Wang, C., Zhou, L., Yang, T., Zhu, Q., Chu, Z., Zhang, J., Jiang, M., Wang, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.05.038 · Cited by 1
Metadata
- Authors
- Sanada, T., Takaesu, G., Mashima, R., Yoshida, R., Kobayashi, T., & Yoshimura, A.
- Affiliations
- Kyushu University (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Yoshimura, Akihiko
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 283
- Issue
- 49
- Pages
- 33858-33864
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2662213
- OpenAlex
- W2067240517
- Cited by
- 66
- References
- 27
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 6 · 2012: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4310 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TLR4 signaling, IPS-1, TRAF6, TRAF3, TRIF, NF-κB activation, IRF3 activation, interferon-beta, septic shock, interferon-stimulated genes, negative regulation of innate immunity
- MeSH terms
- DEAD Box Protein 58, Roundabout Proteins, Animals, Gene Expression Regulation, Humans, Lipopolysaccharides, Membrane Proteins, Mice, Transgenic, Nerve Tissue Proteins, Receptors, Cell Surface, Receptors, Immunologic, Signal Transduction, NF-kappa B, Vesiculovirus, Intracellular Signaling Peptides and Proteins, Interferon Regulatory Factor-3, Toll-Like Receptor 4, Mice, DEAD-box RNA Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.